FI66370C - Foerfarande foer framstaellning av nya farmakologiskt anvaendbara piperidinopropylderivat - Google Patents

Foerfarande foer framstaellning av nya farmakologiskt anvaendbara piperidinopropylderivat Download PDF

Info

Publication number
FI66370C
FI66370C FI800407A FI800407A FI66370C FI 66370 C FI66370 C FI 66370C FI 800407 A FI800407 A FI 800407A FI 800407 A FI800407 A FI 800407A FI 66370 C FI66370 C FI 66370C
Authority
FI
Finland
Prior art keywords
group
hydroxy
propoxy
piperidino
general formula
Prior art date
Application number
FI800407A
Other languages
English (en)
Finnish (fi)
Other versions
FI800407A (fi
FI66370B (fi
Inventor
Walter-Gunar Friebe
Helmut Michel
Carl Heinz Ross
Fritz Wiedemann
Gisbert Sponer
Wolfgang Schaumann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI800407A publication Critical patent/FI800407A/fi
Publication of FI66370B publication Critical patent/FI66370B/fi
Application granted granted Critical
Publication of FI66370C publication Critical patent/FI66370C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Claims (3)

1. Förfarande för framställning av farmakologiskt användbara piperiäinopropylderivat med den allmänna formeln I ?3 /-v O-CH -CH-CH -N y CHo-0-B Λ-a (i> r, H- i 1 1 yJ— V. R2 R4 i vilken formel och R2, vilka kan vara lika eller olika, betecknar en väte-· atom eller en -Cg-alkylgrupp eller bildar tillsammans en C2-C4-alkylenrest, betecknar väte eller en grupp -O-Rg, väri betecknar väte eller en acetyl-, pivaloyl- eller bensoylrest, betecknar väte eller en formylrest, A betecknar en grupp , varvid X1 och Y1 kan vara lika eller olika och betecknar var för sig en kväveatom eller en grupp -C=, K väri Rg betecknar väte, en C.j-Cg-alkylgrupp, som eventuellt är substituerad med en grupp -O-R,., en karboxyl- eller C1-C/r-alkoxikarbonylgrupp, en grupp X2~Y2/ väri X2 betecknar en ^CH2~grupp eller en grupp ^N-R^, väri R^ är väte eller en C.j-Cg-alkylgrupp, och Y2 en 7ACH2~grupp eller en grupp ^;C=Z, varvid Z betecknar en syre-eller svavelatom, eller en grupp -CRg=CRg-, väri Rg och Rg tillsammans betecknar en -CH=CH-CH=CH-brygga, med det villkoret, att Y^ resp. Y2 är bundna vid resten 3^N-R4 i den allmänna formeln I, och B betecknar en pyridyl-, pyrimidyl-, bensimidazolinonyl-, bens-imidazolinyl-, benstriazolyl-, indazolyl-, bensodioxolanyl-eller karbazolylrest eller, för det fall A betecknar X2“Y2 eller -CRg=CRg-, även en fenylrest, som eventuellt är substituerad med en eller flera halogen-, hydroxi- eller C^-Cg-alkylgrupper, som eventuellt har en hydroxi- eller karboxamido- substituent, eller e,-C^-alkoxi-, amino-, karboxamido-, C..-C,- I o Ib alkylkarbonyland.no-, acetyl- eller -Cg-alkylsulfonylamino- grupper, och deras farmakologiskt acceptabla salter, 40 66370 kännetecknat av att man a) omsätter en förening med den allmänna formeln II o-ch2-u-ch2-v "· -fe-K. R2 med en förening med den allmänna formeln III H-l/ y~CH2-Q-B (III) i vilka formler R1, R2, R4, A och B har den ovan angivna be-tydelsen, V betecknar en reaktiv rest och U en grupp ^=C=0, ^CH-R^ eller ^CH-O-E, varvid R^ har den ovan angivna bety-delsen och E bildar tillsammans med V en enkel-bindning, och för det fall U betecknar en grupp ^TC=0, därpä reducerar, eller b) omsätter en förening med den allmänna formeln IV OH R2 R4 med en förening med den allmänna formeln V v-ch2-u-ch2-i/ \- ch2-o-b (V) i vilka formler R^, R2, R^, A, B, U och V har den ovan angivna betydelsen, och för det fall U betecknar en grupp ^.0=0, därpä reducerar, eller c) omsätter en förening med den allmänna formeln VI 66370 41 RT • 3 /—\ O-CH -CH-CH_-N V- CH„—O—B , 2 v.y 2
1 XH m> NH R„ I R4 i vilken formel , R^, R^ , R^ och B har den ovan angivna be-tydelsen och X betecknar HX1 eller X^, varvid, för det fall att A betecknar en -X^=Y^-grupp, en förening med den allmänna formeln VI, i vilken X betecknar gruppen HX^, omsättes med en förening med den allmänna formeln Vila L1 ^ L2 -Y1 (Vila) L3 i vilken formel Y^ har den ovan angivna betydelsen, betecknar en väteatom, en hydroxigrupp eller en reaktiv rest T, L2 betecknar en väteatom eller en reaktiv rest T, och L·^ betecknar en väteatom eller bildar tillsammans med gruppen L2 en syreatom, eller varvid, för det fall att A betecknar en X2-Y2~grupp, en förening med den allmänna formeln VI, i vilken formel X betecknar gruppen X2, omsättes med en förening med den allmänna formeln Vllb L1 ^ Y2 (Vllb) L2*^ i vilken formel och Y2 har den ovan angivna betydelsen, och L2' betecknar en väteatom eller en reaktiv rest T, och cyklise-rar, eller d) reducerar och cykliserar en förening med den allmänna formeln VIII
FI800407A 1979-02-16 1980-02-11 Foerfarande foer framstaellning av nya farmakologiskt anvaendbara piperidinopropylderivat FI66370C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19792905876 DE2905876A1 (de) 1979-02-16 1979-02-16 Neue piperidinopropylderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2905876 1979-02-16

Publications (3)

Publication Number Publication Date
FI800407A FI800407A (fi) 1980-08-17
FI66370B FI66370B (fi) 1984-06-29
FI66370C true FI66370C (fi) 1984-10-10

Family

ID=6063043

Family Applications (1)

Application Number Title Priority Date Filing Date
FI800407A FI66370C (fi) 1979-02-16 1980-02-11 Foerfarande foer framstaellning av nya farmakologiskt anvaendbara piperidinopropylderivat

Country Status (16)

Country Link
US (1) US4288442A (sv)
EP (1) EP0014928B1 (sv)
JP (1) JPS55113777A (sv)
AT (1) ATE968T1 (sv)
AU (1) AU529849B2 (sv)
CA (1) CA1115703A (sv)
CS (2) CS226008B2 (sv)
DD (1) DD149069A5 (sv)
DE (2) DE2905876A1 (sv)
DK (1) DK65780A (sv)
ES (1) ES8102719A1 (sv)
FI (1) FI66370C (sv)
HU (1) HU184238B (sv)
IL (1) IL59351A (sv)
SU (2) SU1021342A3 (sv)
ZA (1) ZA80787B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2901336A1 (de) 1979-01-15 1980-07-24 Boehringer Mannheim Gmbh Neue arylether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
SE8003278L (sv) 1979-05-04 1980-11-05 Continental Pharma Fenyletylaminderivat
DE3200304A1 (de) * 1981-01-16 1982-08-26 Sandoz-Patent-GmbH, 7850 Lörrach 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
DE3209271A1 (de) * 1982-03-13 1983-09-15 Boehringer Mannheim Gmbh, 6800 Mannheim Bicyclische phenolether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
ZA848275B (en) * 1983-12-28 1985-08-28 Degussa New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
US5231184A (en) * 1987-11-23 1993-07-27 Janssen Pharmaceutica N.V. Pridazinamine derivatives
DE3839743A1 (de) * 1988-11-25 1990-05-31 Hoechst Ag Verfahren zur herstellung von benzimidazolonen
US5082847A (en) * 1990-07-18 1992-01-21 Syntex (U.S.A.) Inc. Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility
US5741789A (en) 1995-01-17 1998-04-21 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5627196A (en) * 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5789402A (en) * 1995-01-17 1998-08-04 Eli Lilly Company Compounds having effects on serotonin-related systems
US5614523A (en) * 1995-01-17 1997-03-25 Eli Lilly And Company Compounds having effects on serotonin-related systems

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE255000C (sv) *
DE2550001A1 (de) 1975-11-07 1977-05-12 Boehringer Mannheim Gmbh Neue indol-derivate und verfahren zu ihrer herstellung
DE2701794A1 (de) * 1976-01-21 1977-07-28 Ciba Geigy Ag Oxigenierte n-aryl-diazacyclen
US4110333A (en) * 1976-05-17 1978-08-29 Janssen Pharmaceutica N.V. 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds
US4146630A (en) * 1976-11-12 1979-03-27 Boehringer Mannheim Gmbh Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers
DE2737630A1 (de) * 1977-08-20 1979-03-01 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives

Also Published As

Publication number Publication date
ZA80787B (en) 1981-03-25
CS226008B2 (en) 1984-03-19
CS226021B2 (en) 1984-03-19
AU5540980A (en) 1980-08-21
SU1021342A3 (ru) 1983-05-30
DE3060353D1 (en) 1982-06-24
EP0014928A1 (de) 1980-09-03
ES488401A0 (es) 1981-02-16
FI800407A (fi) 1980-08-17
IL59351A0 (en) 1980-05-30
IL59351A (en) 1984-01-31
FI66370B (fi) 1984-06-29
HU184238B (en) 1984-07-30
EP0014928B1 (de) 1982-05-05
AU529849B2 (en) 1983-06-23
CA1115703A (en) 1982-01-05
ES8102719A1 (es) 1981-02-16
DK65780A (da) 1980-08-17
US4288442A (en) 1981-09-08
JPS55113777A (en) 1980-09-02
DD149069A5 (de) 1981-06-24
DE2905876A1 (de) 1980-08-28
ATE968T1 (de) 1982-05-15
SU1241987A3 (ru) 1986-06-30

Similar Documents

Publication Publication Date Title
FI66370C (fi) Foerfarande foer framstaellning av nya farmakologiskt anvaendbara piperidinopropylderivat
US6130235A (en) Compounds and methods to treat cardiac failure and other disorders
US4346093A (en) Heterocyclic oxypropanolamine compounds and pharmaceutical compositions
US20030073699A1 (en) Compounds and methods to treat cardiac failure and other disorders
AU2004203356A1 (en) Indole-type derivatives as inhibitors of p38 kinase
EA002778B1 (ru) СЕЛЕКТИВНЫЕ β-АДРЕНЕРГИЧЕСКИЕ АГОНИСТЫ
WO1999061426A1 (en) Heterocyclic compounds and methods to treat cardiac failure and other disorders
WO2002042292A2 (en) Indol derivative and their use as inhibitors of p38 kinase
PL196774B1 (pl) Pochodne indolilopiperydyny jako środki przeciwhistaminowe i przeciwalergiczne
FI62077C (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara fenoximetylpiperidinopropanolderivat
JPH0567624B2 (sv)
US5330986A (en) Indole-7-carboxamide derivatives
US6340685B1 (en) Compounds and methods to treat cardiac failure and other disorders
US20040053956A1 (en) Isoquinoline derivatives useful in the treatment of cns disorders
US4363808A (en) N-(3-Phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
US4337250A (en) Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
PL112154B1 (en) Method of preparation of novel aminopropanol derivatives
US20070232619A1 (en) Piperazine Derivatives of Dialkyl Oxindoles
US4432978A (en) Hexahydro-trans-pyridoindole
US4438116A (en) Quinoxalinyloxy-amino-propanol compounds with blood pressure lowering and β-blocking properties, their use and pharmaceutical compositions containing them
JPS6345667B2 (sv)
US4434174A (en) Treating cardiovascular diseases with N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
FR2605008A1 (fr) Derives d'imidazo (4,5-b)pyridinone-2, leur preparation et leur application en therapeutique
US4431649A (en) Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4427679A (en) Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BOEHRINGER MANNHEIM GMBH